inRegen   Report issue

For profit Phase 1 Phase 2
Founded: Grand Cayman Cayman Islands (2016)
Status: No NME R&D (2016)

Organization Overview

First Clinical Trial
2018
NCT03270956
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

inRegen